News

FMR LLC and Abigail P. Johnson filed Amendment No. 3 to their Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of Roblox Corp Class A Common Stock as of September 30, 2026.

FMR LLC filed Amendment No. 5 to its Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of approximately 12,195,540.29 shares of Silicon Motion Technology Corporation common stock as of September 30, 2026.

FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of 13,180,206 shares of common stock in Silence Therapeutics PLC as of September 30, 2026.

FMR LLC and Abigail P. Johnson filed Amendment No. 2 to a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of common stock in Praxis Precision Medicines Inc. (NASDAQ:PRAX) as of September 30, 2026.

FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of Class A Common Stock in Select Water Solutions Inc. as of September 30, 2026.

FMR LLC and Abigail P. Johnson filed Amendment No. 6 to Schedule 13G with the SEC on November 4, 2026, disclosing beneficial ownership of Class A Common Stock of Perella Weinberg Partners as of September 30, 2026.

FMR LLC and Abigail P. Johnson filed Amendment No. 4 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 37,293,854 shares of Sana Biotechnology Inc. common stock as of September 30, 2026.